focus -WSS

focus

author：Wikipedia 2025-09-30 18:59:10 - browse：11996

How does a drug industry lobbying group move forward after years of upheaval, including having four CEOs in four years?

This week on “The Readout LOUD,” STAT’s Chief Washington Correspondent Rachel Cohrs Zhang joins us to discuss the layoffs at trade group BIO and how things may be changing at the trade group. We also invite STAT reporter Eric Boodman on to talk about his new investigative series of stories exploring how Black women with sickle cell disease were coerced into getting sterilized.

To read the first article in the Coercive Care investigative series and find future installments, go here; For more on the layoffs at BIO, go here; To keep tabs on health policy and BIO’s reorganization, sign up for the D.C. Diagnosis newsletter here; And you can sign up for Adam’s new newsletter, Biotech Scorecard, here.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： STAT Readout Newsletter: Biotech news today

hotspot

WSS

UCLA team creates talking throat patch for voice disorders

HHS secretary Becerra pressed on Change HealthCare cyberattack

STAT Readout Newsletter: Biotech news today

Steward Health Care Massachusetts hospitals face fiscal disaster

Study on Amgen’s bispecific immunotherapy produces positive data

Roche acquires Telavant from Roivant, adding experimental IBD treatment

hotspot

focus

focus

After affirmative action ruling, medical educators look to 'holistic review'

RaDonda Vaught links Vanderbilt hospital issues to patient death

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Activists slam private health insurers over coverage restrictions

Smaller biotechs seek to piggyback on weight loss drug boom

George Santos makes 1st court appearance after pleading not guilty to 13 counts

As AI in medicine takes off, can 'human in the loop' prevent harm?

Drug repurposing or repositioning? The language matters

Cassava Sciences’ Alzheimer’s clinical trials should be halted

knowledge

FDA advisers back CAR

Ebola: Gilead Sciences antiviral shows promise as new treatment

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

Study on Amgen’s bispecific immunotherapy produces positive data

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

focus

hotspot

entertainment

hotspot